Europe Companion Animal Diagnostics Market Dynamics and Trends by 2027

The Europe companion animal diagnostics market is expected to reach US$ 792.8 million by 2027 from US$ 613.6 million in 2019; it is estimated to grow at a CAGR of 3.8% from 2020 to 2027.

The companion animal diagnostics product takes care of the diagnosis of different of diseases in the pet animals. These product deals with the epidemiology and pathogenesis of the domestic animal and prevents further complications with health of the pet as well as the owner. These products are normally used for the animals like cats, dogs, horses.

Arthritis and other orthopedic conditions, chronic kidney disease, cancer, hepatitis and other liver diseases, skin allergies, diabetes mellitus, inflammatory bowel disease, and thyroid disorders are among the common chronic diseases in pets. Cancer is widespread in animals and affects pet as well as wild animals. Animals have been diagnosed with various types of cancer till date, which have symptoms similar to humans, including unexplained weight loss, abnormal swelling, and lethargy. As per the veterinary cancer society, cancer is a leading cause of death in 47% of dogs, especially in dogs with >10 years of age, and 32% of cats. Further, FETCH a Cure, a nonprofit organization, has estimated that over 6 million dogs and ~6 million cats would be diagnosed with cancer in 2020. Furthermore, as per the Pet Cancer Facts and Figures, one in four dogs and one in five cats develop cancer in their lifetime.

Similarly, according to the People's Dispensary for Sick Animals (PDSA), In the UK, it’s estimated that 40% of dogs and 53% of cats are overweight or obese, which is only set to get worse. Pet obesity is on the rise in the UK. 81% of vets and nurses report seeing an increase in the number of overweight animals. Additionally, according to the Arthritis Foundation, ~20% of all adult dogs suffer from arthritis. Such growing prevalence of chronic diseases have become more significant factor, raising the demand for animal health, and this has triggered companies to produce advanced pharmaceuticals and vaccines to help animal owners or other stakeholders to maintain the overall health of animals.

The countries in Europe are highly affected due to the Covid-19 pandemic. However, COVID-19 has not affected animal health. The animal health industry in European countries is minimally affected. Pharmaceutical and biotechnology companies operating in the veterinary sectors are not affected; their operations are carried out normally. However, the companies may face challenges for supplying the products in different countries due to lockdown. Thus, the Europe companion animal diagnostics market is least affected by the COVID-19 in the European region.

Rest of Europe Companion Animal Diagnostics Market, Revenue and Forecast to 2027 (US$ Mn)

EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION

By Technology

• Immunodiagnostics
  • Lateral Flow Assays
  • Elisa Tests
  • Allergen-Specific Immunodiagnostic Tests Diagnostics
  • Immunoassay Analyzers
• Clinical Biochemistry
  • Clinical Chemistry Analysis
  • Glucose Monitoring
  • Blood Gas Electrolyte Analysis
• Hematology
• Urinalysis
• Molecular Diagnostics

By Application

• Bacteriology
• Clinical Pathology
• Virology
• Parasitology
• Others

By Animal Type

• Dogs
• Cats
• Horses
• Others

By End-User

• Diagnostic Laboratories
• Veterinary Hospitals and Clinics
• Research Institutes and Universities

By Country

• Germany
• France
• United Kingdom
• Italy
• Spain

Company Profiles

• Zoetis Inc
• Randox Laboratories, Ltd.
• Idexx Laboratories, Inc.
• IDvet
• Virbac

Europe Companion Animal Diagnostics Report Scope